Healthcare Triangle, Inc.
HCTIHealthcareNASDAQHealth Information Services
Scan Results
Daily timeframePart of the healthcare sector, Healthcare Triangle, Inc. (HCTI) is listed under Health Information Services. The company carries a $3.6M market cap, placing it firmly in the micro-cap category. It provides a suite of software, solutions, platforms, and services that enables healthcare and pharma organizations to deliver personalized healthcare, precision medicine, advances in drug discovery, development and efficacy, collaborative research and development, respond to evidence, and accelerate their digital transformation.
Market Cap
$3.6M
Beta
1.09
P/E (TTM)
0.00
P/E (Fwd)
-0.18
EPS (TTM)
$402.84
EPS (Fwd)
$-10.14
ROE
-45.6%
ROA
-16.3%
Cash
$4.3M
Total Debt
$10.9M
Free CF
-$9.9M
52W Change
-99.4%
Annual Financials
Cash vs Debt
Where HCTI stands vs its 150-day and 200-day moving averages
As of the July 9, 2026 close, HCTI finished 92.32% below its 150-day moving average ($22.13) and 96.91% below its 200-day moving average ($55.07). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is HCTI overbought or oversold?
At the July 9, 2026 close, HCTI's RSI(14) was 26.6, in oversold territory (below 30). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
Healthcare Triangle, Inc. carries $10.9M in total debt against $4.3M in cash reserves — debt is roughly 2.5x the cash position. Managing this leverage effectively will be important for long-term financial stability. Free cash flow is running at -$9.9M, which bears watching. Negative free cash flow can be acceptable during heavy investment periods but needs to improve over time. Return on equity stands at -45.6%, which is negative for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. Revenue has pulled back from $45.9M (2022) to $13.9M (2025), a 70% decline worth watching.
Negative free cash flow means the company is currently spending more than it generates, which may require future fundraising or debt if the trend continues. Understanding these risk dimensions helps frame what to watch going forward as conditions evolve for Healthcare Triangle, Inc. and its sector.